Dorota Broniszczak

Dorota Broniszczak

Auto-generated profile, based on publicly available information

Dorota Broniszczak

Department of Pediatric Surgery and Organ Transplantation, Children's Memorial Health Institute, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2009 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
HIHor Ismail
Hor Ismail
DBD. Broniszczak
D. Broniszczak
PKPiotr Kaliciński
Piotr Kaliciński
MMMałgorzata Markiewicz-Kijewska
Małgorzata Markiewicz-Kijewska
JTJ. Teisseyre
J. Teisseyre
MTM. Teisserye
M. Teisserye

1 July 2012 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
HIHor Ismail
Hor Ismail
DBDorota Broniszczak
Dorota Broniszczak
PKPiotr Kaliciński
Piotr Kaliciński
BDBozenna Dembowska-Baginska
Bozenna Dembowska-Baginska
DPDanuta Perek
Danuta Perek
MMMalgorzata Markiewicz
Malgorzata Markiewicz

1 November 2013 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
HIHor Ismail
Hor Ismail
BDBozenna Dembowska-Baginska
Bozenna Dembowska-Baginska
DBDorota Broniszczak
Dorota Broniszczak
PKPiotr Kaliciński
Piotr Kaliciński
PMPrzemysław Maruszewski
Przemysław Maruszewski
DPDanuta Perek
Danuta Perek

1 June 2006 in Transplantation Proceedings
Verified
Journal Article
Closed access
DBD. Broniszczak
D. Broniszczak
MSMarek Szymczak
Marek Szymczak
AKA. Kamiński
A. Kamiński
ACA. Chyżyńska
A. Chyżyńska
HIHor Ismail
Hor Ismail
PKPiotr Kaliciński
Piotr Kaliciński

28 October 2009 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
DBD. Broniszczak
D. Broniszczak
HIHor Ismail
Hor Ismail
PNP. Nachulewicz
P. Nachulewicz
MSMarek Szymczak
Marek Szymczak
TDT. Drewniak
T. Drewniak
PKPiotr Kaliciński
Piotr Kaliciński
Introduction: Various congenital and acquired diseases of the lower urinary tract can lead to chronic renal failure requiring renal replacement therapy. Aim: The aim of the study was to assess problems and results of kidney transplantation in children with significant lower urinary tract dysfunction. Materials and Methods: Between 1984 and 2007, there were 33 kidney transplantations in children with end-stage renal disease and severe lower tract dysfunction out of 539 kidney transplantations performed in our department. The patients were 23 males and 10 females. Thirty patients received a kidney from a deceased donor, the remaining 3 from a living related donor. The age at transplantation ranged from 2.25 years to 19 years. In 26 patients an ileal conduit modo Bricker was created (in 21 patients at transplant operation). Bladder augmentation was performed in 6 patients and a continent urinary reservoir was created in 1. Results: Post-transplant follow-up ranged from 7 to 88 months (mean 32 months). Overall patient survival is 100% and graft survival is 97%. Creatinine concentrations ranged from 0.3 to 3.4 mg% (mean 0.92 mg%). Surgical complications were diagnosed in 16 patients. All surgical complications were treated successfully and none of them caused graft loss. Urinary tract infections (UTI) were the most commonly observed complication, occurring in 26/33 (78%) patients, but the majority of these UTI were asymptomatic and had no influence on graft function. Conclusions: Kidney transplantation in children with lower urinary tract dysfunction and end-stage renal failure offers excellent medium term results in our experience, despite the creation of non-standard urinary drainage. Recurrent urinary tract infections are the most common complications in these patients, but in the majority of cases this does not lead to impairment of graft function.

23 February 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMarek Szymczak
Marek Szymczak
PKPiotr Kaliciński
Piotr Kaliciński
GKGrzegorz Kowalewski
Grzegorz Kowalewski
DBDorota Broniszczak
Dorota Broniszczak
MMMałgorzata Markiewicz-Kijewska
Małgorzata Markiewicz-Kijewska
WPWaldemar Patkowski
Waldemar Patkowski
Living donor liver transplantation (LDLT) in patients with acute liver failure (ALF) has become an acceptable alternative to transplantation from deceased donors (DDLT). The aim of this study was to analyze outcomes of LDLT in pediatric patients with ALF based on our center’s experience. We enrolled 63 children (at our institution) with ALF who underwent liver transplantation between 1997 and 2016. Among them 24 (38%) underwent a LDLT and 39 (62%) received a DDLT. Retrospectively analyzed patient clinical data included: time lapse between qualification for transplantation and transplant surgery, graft characteristics, postoperative complications, long-term results post-transplantation, and living donor morbidity. Overall, we have made a comparison of clinical results between LDLT and DDLT groups. Follow-up periods ranged from 12 to 182 months (median 109 months) for LDLT patients and 12 to 183 months (median 72 months) for DDLT patients. The median waiting time for a transplant was shorter in LDLT group than in DDLT group. There was not a single case of primary non-function (PNF) in the LDLT group and 20 out of 24 patients (83.3%) had good early graft function; 3 patients (12.5%) in the LDLT group died within 2 months of transplantation but there was no late mortality. In comparison, 4 out of 39 patients (10.2%) had PNF in DDLT group while 20 patients (51.2%) had good early graft function; 8 patients (20.5%) died early within 2 months and 2 patients (5.1%) died late after transplantation. The LDLT group had a shorter cold ischemia time (CIT) of 4 hours in comparison to 9.2 hours in the DDLT group (p<0.0001). LDLT is a lifesaving procedure for pediatric patients with ALF. Our experience showed that it may be performed with very good results, and with very low morbidity and no mortality among living donors when performed by experienced teams following strict procedures.